Cogent Biosciences (COGT) Receivables (2017 - 2019)
Historic Receivables for Cogent Biosciences (COGT) over the last 3 years, with Q4 2019 value amounting to $2.0 million.
- Cogent Biosciences' Receivables rose 1990.41% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year increase of 1990.41%. This contributed to the annual value of $2.0 million for FY2019, which is 1990.41% up from last year.
- According to the latest figures from Q4 2019, Cogent Biosciences' Receivables is $2.0 million, which was up 1990.41% from $880000.0 recorded in Q3 2019.
- Over the past 5 years, Cogent Biosciences' Receivables peaked at $2.0 million during Q1 2019, and registered a low of $830000.0 during Q4 2017.
- Over the past 3 years, Cogent Biosciences' median Receivables value was $1.5 million (recorded in 2019), while the average stood at $1.5 million.
- Per our database at Business Quant, Cogent Biosciences' Receivables skyrocketed by 10096.39% in 2018 and then plummeted by 3798.45% in 2019.
- Quarter analysis of 3 years shows Cogent Biosciences' Receivables stood at $830000.0 in 2017, then surged by 100.96% to $1.7 million in 2018, then grew by 19.9% to $2.0 million in 2019.
- Its Receivables was $2.0 million in Q4 2019, compared to $880000.0 in Q3 2019 and $1.5 million in Q2 2019.